Latest news
Price to earnings forward of Walvax Biotechnology Co., Ltd. Class A – SZSE:300142 - TradingViewTradingView · Sat, 01 Aug 2026 08:11:57 GMTCellOrigin Unveils Two Novel Solid-Tumor Cell Therapy Candidates at ASCO 2026, Partners with Walvax for In Vivo CAR Clinical Trial - The Manila TimesThe Manila Times · Fri, 31 Jul 2026 06:45:44 GMT